Mr. James Howard-Tripp reports

GENENEWS ANNOUNCES ELECTION OF DIRECTORS

GeneNews Ltd. shareholders elected all of the nominees listed in the company's management information circular dated May 30, 2018, as directors of GeneNews at the company's annual and special meeting of shareholders held on June 28, 2018. The results of the vote are provided in the attached table.

Nominee                 Votes for     Votes withheld      For %      Withheld %

James Howard-Tripp     22,641,434            187,600      99.18            0.82                         
Rory Riggs             22,780,534             48,500      99.79            0.21                         
Garth MacRae           22,662,184            166,850      99.27            0.73                         
Harry Glorikian        22,668,184            160,850      99.30            0.70                         
Leslie Auld            22,635,934            193,100      99.15            0.85                         
Thomas Stewart         22,662,984            166,050      99.27            0.73                          

Additionally, the resolutions to approve the appointment of the auditor and the various financings were approved by shareholders as well.

About GeneNews Ltd.

GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. The company's mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease.